The potential role of Fluoroquinolones in the management of Covid-19 a rapid review
Authors:
- Zoheir A. DamanhouriZDZoheir A. Damanhouri
- Huda M. AlkreathyHAHuda M. Alkreathy
- Ahmed S. AliAAAhmed S. Ali
- Shahid KarimSKShahid Karim
- 1 January 2021
- journal article
- review article
- Published by Polaris in Journal Of Advanced Pharmacy Education And Research
- Vol. 11 (1) , 128-134
Abstract
COVID-19 is a pandemic viral pneumonia caused by β-coronavirus SARS-CoV-2. It is associated with many complications including extreme systemic inflammatory response which eventually causes acute respiratory distress syndrome (ARDS), hypercoagulability, cytokine storm, failure of vital organs, and a high incidence of death. Bacterial secondary infecKeywords
This publication has 87 references indexed in Scilit:
- Possible antiviral effect of ciprofloxacin treatment on polyomavirus BK replication and analysis of non-coding control region sequencesVirology Journal, 2013
- In vitro antiviral activity of fluoroquinolones against African swine fever virusVeterinary Microbiology, 2013
- Levofloxacin Inhibits Rhinovirus Infection in Primary Cultures of Human Tracheal Epithelial CellsAntimicrobial Agents and Chemotherapy, 2012
- Pharmacokinetics of Ciprofloxacin and Its Penetration into Bronchial Secretions of Mechanically Ventilated Patients with Chronic Obstructive Pulmonary DiseaseAntimicrobial Agents and Chemotherapy, 2011
- Fluoroquinolones Inhibit HCV by Targeting Its HelicaseAntiviral Therapy, 2011
- Determination of the inhibitory potential of 6 fluoroquinolones on CYP1A2 and CYP2C9 in human liver microsomesActa Pharmacologica Sinica, 2008
- Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolutionProceedings of the National Academy of Sciences, 2008
- SARS-Coronavirus Replication/Transcription Complexes Are Membrane-Protected and Need a Host Factor for Activity In VitroPLOS Pathogens, 2008
- Immunomodulatory Activities of FluoroquinolonesInfection, 2005
- Effects of ofloxacin for type C hepatitisInternational Hepatology Communications, 1993